In the latest news, Sartorius AG (Sartorius Stedim Biotech) will continue its strategic collaboration with portfolio company RoosterBio to advance downstream purification processes for the manufacture of exosomes.  Through this collaboration, Sartorius and RoosterBio will provide best-in-class solutions and expertise for a human mesenchymal stem/stromal cell (hMSC) - based exosome production platform that delivers industry-leading yield, purity, and potency.

Sartorius and RoosterBio will leverage the data from this collaboration to provide application notes, technology presentations, and other guidance materials designed to address the most significant challenges faced by the biomanufacturing industry.